Ovatodiolide Oxidation Derivative for Solubility and Oral Absorption

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Ovatodiolide exhibits poor solubility, leading to reduced drug efficacy and difficulties in developing an effective oral dosage form due to poor absorption.

Innovation Solution

A derivative of ovatodiolide, named Ova-Oxy, is synthesized through oxidation with H2O2 and methyltrioxorhenium (VII) to enhance solubility and cytotoxicity against cancer cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If ovatodiolide is used as an anti-cancer agent, then it exhibits cytotoxic activity against cancer cells, but it has poor solubility leading to reduced drug efficacy and poor absorption

Engineering Contradiction:
Improvecytotoxic activityVSAvoidsolubility
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent applies parameter changes by chemically modifying the parent compound ovatodiolide to create derivatives with altered molecular structures. Specifically, various substituents are introduced at different positions of the diterpenoid core structure to enhance solubility while preserving or improving cytotoxic activity against cancer cells.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates composite molecular structures by combining the ovatodiolide core with additional functional groups and substituents. These composite derivatives integrate the anti-cancer properties of the parent compound with solubility-enhancing moieties, achieving a balance between efficacy and pharmacokinetic properties.

Inventive Principle:
Principle #40Composite materials

2Ease of operation

If ovatodiolide is administered orally, then it can be delivered systemically, but poor absorption reduces drug efficacy

Engineering Contradiction:
Improveoral administrationVSAvoiddrug efficacy
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent modifies molecular parameters of ovatodiolide through derivative synthesis to improve oral bioavailability. By adjusting hydrophobicity, molecular size, and functional group composition, the derivatives achieve better absorption characteristics while maintaining therapeutic activity.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Ova-Oxy demonstrates remarkable cytotoxic effects on various cancer cell lines, including kidney, lung, colorectal, liver, prostate, pancreas, and gastric adenocarcinoma cells, offering potential as a therapeutic agent.

Implementation Method 1

A derivative of ovatodiolide, named Ova-Oxy, is synthesized through oxidation with H2O2 and methyltrioxorhenium (VII)

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentUS20250360100A1Anti-cancer derivatives of ovatodiolide and use thereof
Publication Date: 2025.11.27 ARJIL BIOTECH HLDG CO LTD
  • US20250360100A1 patent drawing
  • US20250360100A1 patent drawing
  • US20250360100A1 patent drawing

AI summary

The present invention pertains to a new derivative of ovatodiolide, which has unexpectedly good cytotoxicity in cancer cells. Also provided are the preparation process and the use of the new derivative of ovatodiolide.